Following on from advice received from the company, NICE has decided to suspend this appraisal from its work programme whilst the company confirm their regulatory filing plans.
As this appraisal has been referred NICE will continue to monitor any development and will update interested parties if the situation changes.
| Status | Suspended |
| Technology type | Medicine |
| Decision | Awaiting decision |
| Process | STA Standard |
| ID number | 6375 |
Email enquiries
- If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 28 March 2024 | Suspended. Following on from advice received from the company, NICE has decided to suspend this appraisal from its work programme whilst the company confirm their regulatory filing plans. As this appraisal has been referred NICE will continue to monitor any development and will update interested parties if the situation changes. |
| 25 October 2023 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
| 25 October 2023 | Topic selection |
For further information on our processes and methods, please see our CHTE processes and methods manual